NSE · Basic Materials · Specialty Chemicals
EPS came in at 3.73 against a street estimate of 3.30 — a beat of 13.0%.
with an average price target of ₹1,215.71.
| Document | Date |
|---|---|
| Q1 FY27 earnings call ANUPAM RASAYAN INDIA LIMITED – Q1 FY27 SUMMARY HEADLINE NUMBERS • Consolidated Total Income: INR 668 crores, up 36% year-on-year • Revenue from Oper | 2026-08-20 |
| Investor presentation · Q1 FY27 ANUPAM RASAYAN INDIA LTD — Q1 FY27 INVESTOR SUMMARY HEADLINE NUMBERS • Consolidated Total Revenue: ₹6,675 Mn | Y-o-Y growth: 36% • Consolidated EBIT | 2026-08-14 |
| Quarterly results · Q1 FY27 ANUPAM RASAYAN INDIA LTD – Q1 FY27 SUMMARY HEADLINE NUMBERS • Total Revenue Q1FY27: Rs 6,675 Mn (up 36% YoY from Rs 4,907 Mn in Q1FY26) • EBITDA (in | 2026-08-14 |
| Q4 FY26 earnings call ANUPAM RASAYAN INDIA LIMITED – Q4 FY26 SUMMARY HEADLINE NUMBERS • Consolidated Revenue FY26: INR 2,384 crores (up 65% Y-o-Y from INR 1,448 crores in | 2026-05-30 |
| Investor presentation · Q4 FY26 ANUPAM RASAYAN INDIA LIMITED – BLISS GVS PHARMA ACQUISITION SUMMARY HEADLINE NUMBERS • Bliss GVS Pharma Revenue (FY26): Rs 927 crore • Bliss GVS Pha | 2026-05-23 |
| Quarterly results · Q4 FY26 ANUPAM RASAYAN INDIA LTD. – FINANCIAL RESULTS SUMMARY Q4 & FY26 (Year Ended March 31, 2026) --- HEADLINE NUMBERS • FY26 Total Revenue: Rs 23,836 Mn | 2026-05-23 |
| Investor presentation | 2026-05-23 |
| Q3 FY26 earnings call ANUPAM RASAYAN INDIA LTD – Q3 FY26 EARNINGS SUMMARY HEADLINE NUMBERS • 9M FY26 consolidated revenue: INR 1,730 crores, up 84% year-on-year • 9M FY26 | 2026-02-19 |
Readable in the app.
| Action | Detail | Date |
|---|---|---|
| Dividend | ₹1.50 / share ex-date Sep 18, 2026 | 2026-09-18 |
| Announcement | Date |
|---|---|
| Acquired equity shares in Tanfac Industries through preferential issue Anupam Rasayan India Limited has completed the acquisition of 2,60,065 equity shares in Tanfac Industries Limited through a preferential issue (private placement). The company invested Rs. 6 | 2026-09-09 |
| Acquisition of equity shares in Tanfac Industries Limited via preferential issue Anupam Rasayan India Limited has approved the acquisition of 2,60,065 equity shares (0.73% stake) in its subsidiary Tanfac Industries Limited through a preferential issue at Rs. 2,341 per sh | 2026-09-07 |
| Secures chemical supply contract with global industrial major for six years Anupam Rasayan India Limited, a specialty chemicals manufacturer, has secured a 6-year supply contract with a major US-based specialty metal manufacturer. The company will supply a specialty | 2026-09-05 |
| Open offer to acquire fully paid-up equity shares of Bliss GVS Pharma Anupam Rasayan India Limited announced an open offer to acquire equity shares of Bliss GVS Pharma Limited from public shareholders, in partnership with PAC (likely a financial partner or inv | 2026-07-21 |
| Acquisition of shares in another business entity completed Anupam Rasayan India Limited has informed the Exchange about acquisition of shares | 2026-07-17 |
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Anupam Rasayan India Limited — free to start.
Google PlayApp StoreData updated 2026-09-18.